Patents by Inventor Rosa Rodes-Solanes

Rosa Rodes-Solanes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10106522
    Abstract: The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, a method of synthesis of said compounds, pharmaceutical compositions comprising them and their use in the treatment and/or prevention of conditions mediated by H1 histamine receptor, such as allergic disorders or diseases.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: October 23, 2018
    Assignee: Faes Farma, S.A.
    Inventors: Rosa Rodes Solanes, Roberto Olivera Tizne, Gonzalo Hernández Herrero, Víctor Rubio Royo, Francisco Ledo Gómez
  • Publication number: 20180016251
    Abstract: The invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, a method of synthesis of said compounds, pharmaceutical compositions comprising them and their use in the treatment and/or prevention of conditions mediated by H1 histamine receptor, such as allergic disorders or diseases.
    Type: Application
    Filed: December 28, 2015
    Publication date: January 18, 2018
    Inventors: Rosa RODES SOLANES, Roberto OLIVERA TIZNE, Gonzalo HERNÁNDEZ HERRERO, Victor RUBIO ROYO, Francisco LEDO GÓMEZ
  • Publication number: 20130296346
    Abstract: The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt, prodrug or solvate thereof, a method of synthesis of said compounds, pharmaceutical compositions comprising them and their use as a medicament for treating inflammatory diseases.
    Type: Application
    Filed: November 22, 2011
    Publication date: November 7, 2013
    Applicant: Faes Farma, S.A.
    Inventors: Rosa Rodes Solanes, Neftali Garcia Dominguez, Beatriz Lopez Ortega, Melchor Alvarez De Mon Soto, Antonio De La Hera Martinez, Ana Munoz Munoz, Francisco Ledo Gomez
  • Patent number: 5672604
    Abstract: New 1-phenylmethyl enzimidazole piperazine derivatives of general formula ##STR1## are described wherein R.sup.1 and R.sup.2 can be a hydrogen atom, a halogen atom, a short chain alkyl group, a nitro group, and a hydroxy group, and their addition salts with pharmaceutically acceptable acids.These compounds have pharmacological activity as serotonin 5HT.sub.3 receptor antagonists.
    Type: Grant
    Filed: January 22, 1996
    Date of Patent: September 30, 1997
    Assignee: Fabrica Espanola de Productos Quimicos y Farmaceuticos (FAES)
    Inventors: Aurelio Orjales-Venero, Rosa Rodes-Solanes
  • Patent number: 5256665
    Abstract: A description is made of the preparation of new 2-piperazinylbenzimidazole erivatives, of general formula ##STR1## where R can be a hydrogen atom, a short chain alkyl group and a phenyl radical, substituted in position four by a halogen, and R.sub.1 can be a hydrogen atom, an alkoxycarbonyl radical, a hydroxymethyl group and a diphenylmethyl group, and their addition salts with pharmaceutically acceptable acids.These compounds are pharmacologically active as antagonists of the serotonin 5HT.sub.3 receptors.
    Type: Grant
    Filed: September 15, 1992
    Date of Patent: October 26, 1993
    Assignee: Fabrica Espanola de Productos Quimicos y Farmaceuticos, S.A.
    Inventors: Aurelio Orjales-Venero, Neftali Garcia-Dominguez, Victor Rubio-Royo, Rosa Rodes-Solanes